Home › Funds › ORBIMED ADVISORS LLC › ABVX
ORBIMED ADVISORS LLC position in ABVX
ABIVAX SA · Health Care
ORBIMED ADVISORS LLC reported holding 200,000 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$26.7M, representing 0.54% of its reported portfolio and ranking #48 among its reported holdings. ORBIMED ADVISORS LLC has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's ABVX position evolved
ORBIMED ADVISORS LLC first disclosed a stake in ABVX in Q3 2025 at 380,000 shares (US$32.3M). The position peaked in Q1 2026 at 465,700 shares, worth US$51.9M. Across 4 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 200,000 shares valued at US$26.7M — a reduction of -265,700 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2026 (shares rose 20% over the following quarter), a 57% trim in Q2 2026 (shares fell 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 380.00K | $32.26M | New |
| Q4 2025 | 367.90K | $49.61M | Reduce |
| Q1 2026 | 465.70K | $51.86M | Add |
| Q2 2026 | 200.00K | $26.65M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABVX and 13F data
ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- TCG Crossover Management, LLC 6.01M sh · $800.60M · Q2 2026
- Helikon Investments Ltd 2.79M sh · $371.41M · Q2 2026
- Darwin Global Management, Ltd. 3.62M sh · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M sh · $313.09M · Q2 2026
- Caligan Partners LP 1.56M sh · $207.61M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.31M sh · $174.55M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M sh · $150.92M · Q2 2026
- Logos Global Management LP 1.02M sh · $136.46M · Q2 2026
- Octagon Capital Advisors LP 993.00K sh · $132.33M · Q2 2026
- Eversept Partners, LP 913.88K sh · $121.78M · Q2 2026
- Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 765.33K sh · $101.99M · Q2 2026
- Cormorant Asset Management, LP 675.00K sh · $89.95M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held ABVX?
ORBIMED ADVISORS LLC has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is ORBIMED ADVISORS LLC's current position in ABVX?
As of Q2 2026, ORBIMED ADVISORS LLC holds 200.00K shares of ABVX (ABIVAX SA), valued at $26.65M, representing 0.54% of its reported portfolio and ranking #48.
Has ORBIMED ADVISORS LLC been buying or selling ABVX?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in ABVX. The position peaked in Q1 2026 at 465.70K shares.
Which other funds hold ABVX?
Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.